ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,793.30
1.44%
S&P ASX All Technology
3,068.10
1.62%
Brent Oil
83.555
0.10%
US Dollar vs AUD
1.51563
0.39%
Bitcoin
63,488.34
0.51%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Silence Therapeutics PLC (SLN)

  7. Silence Therapeutics PLC (SLN) News

SLN Silence Therapeutics PLC

21.925
0.025 (0.11%)
Last Updated: 03:08:49
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Silence Therapeutics PLC SLN NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.025 0.11% 21.925 03:08:49
Open Price Low Price High Price Close Price Previous Close
21.68 21.5501 22.40 21.90
more quote information »

Recent News

Date Time Source Heading
30/4/202422:30BWSilence Therapeutics to Participate in Fireside Chat at H.C...
29/4/202422:30BWSilence Therapeutics Announces Retirement of Alistair Gray..
09/4/202401:48BWSilence Therapeutics Announces JAMA Publication of..
13/3/202422:05BWSilence Therapeutics Reports Full Year 2023 Financial..
13/3/202422:03IHMARKETNEWSMixed Futures Amidst Quiet Economic Schedule; Oil Prices..
13/3/202422:00BWSilence Therapeutics Announces Positive Topline 36-Week Data..
29/2/202400:00BWSilence Therapeutics to Report Fourth Quarter and Full Year..
24/2/202400:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/2/202400:00BWSilence Therapeutics Achieves $10 Million Milestone Payment..
15/2/202401:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202400:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202400:00BWSilence Therapeutics Announces Oversubscribed $120 Million..
31/1/202423:00BWSilence Therapeutics to Participate in Fireside Chat at..
01/12/202323:00BWSilence Therapeutics Strengthens Executive Leadership Team..
14/11/202323:00BWSilence Therapeutics Highlights Recent Company Progress and..
08/11/202323:00BWSilence Therapeutics to Present at Jefferies London..
01/11/202322:00BWSilence Therapeutics Announces Positive Topline Results from..
26/9/202321:00BWSilence Therapeutics to Participate in Fireside Chat at..
06/9/202321:00BWSilence Therapeutics to Participate in September Investor..
30/8/202306:01EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
16/8/202321:00BWSilence Therapeutics Reports Second Quarter 2023 Results
02/8/202306:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/7/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/7/202321:00BWSilence Therapeutics Achieves $4 Million in Research..
31/5/202321:00BWSilence Therapeutics to Present at the Jefferies Healthcare..
17/5/202306:00BWSilence Therapeutics Reports First Quarter 2023 Results

Your Recent History

NASDAQ
SLN
Silence Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved